Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Submitted by
admin
on September 13, 2011 - 2:18pm
Source:
Minyanville
News Tags:
Merck
Eli Lilly
Amylin
diabetes
Bydureon
Alkermes
Victoza
Byetta
Novo Nordisk
Headline:
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Do Not Allow Advertisers to Use My Personal information
